Centessa Pharmaceuticals snaps multi-day losing streak; up 10%

For the first time since Oct. 13, Centessa Pharmaceuticals (NASDAQ:CNTA) is showing gains.
In Thursday afternoon trading, the biotech is up 10%.
There is no news or other catalysts that might explain the jump.
However, based on a technical analysis, Centessa (CNTA) deviated two standard deviations lower from its mean touching its lower Bollinger Band level and has snapped up higher, back to its mean level.
From market close Oct. 13 through market close Oct. 19, shares fell ~15%.
Seeking Alpha views Centessa (CNTA) as a hold with high marks for valuation and growth.